Bundibugyo Ebola outbreak DR Congo Uganda no approved vaccine or treatment
Travelers to eastern DR Congo and Uganda now face an Ebola strain with no approved vaccine or treatment. The WHO global health emergency stands at 808 confirmed cases and 192 deaths in DRC, plus 19 cases and two deaths in Uganda, per WHO figures as of June 16.
Anyone planning travel to eastern Democratic Republic of the Congo or Uganda should know they are heading toward an active Ebola outbreak that doctors cannot treat with approved medicine. The strain behind it is Bundibugyo ebolavirus, and the World Health Organization declared the situation a global health emergency on May 16. According to WHO figures published on June 16, the DRC has recorded 808 confirmed cases and 192 confirmed deaths, with 363 people hospitalised in isolation as of June 14. Ituri is the hardest-hit province, accounting for 738 of those cases across 20 health zones. North Kivu has reported 67 cases and South Kivu three. Across the border, Uganda has confirmed 19 cases and two deaths. What makes this outbreak harder to contain is the strain itself. The vaccines and antibody therapies developed during earlier epidemics were built for the Zaire species of the virus, not Bundibugyo. There is no approved vaccine or treatment for this strain. Health authorities are now supporting clinical trials in both countries, testing experimental treatments and using post-exposure prophylaxis for people who have been in contact with patients. The CDC has issued travel health notices for both countries and introduced temporary entry restrictions for non-citizens who have recently been in the affected region. For travelers, aid workers, and the communities living in Ituri and North Kivu, the immediate reality is a fast-moving virus running ahead of the tools available to fight it. Sources: WHO, CDC.